SlideShare a Scribd company logo
Hypertension
Lecture 8
Problem Magnitude
 Hypertension (HTN) is the most common primary diagnosis in America.
 35 million office visits are as the primary diagnosis of HTN.
 50 million or more Americans have high BP.
 Worldwide prevalence estimates for HTN may be as much as 1 billion.
 7.1 million deaths per year may be attributable to hypertension.
Hypertension
 The purpose of the control of blood pressure is to keep blood flow constant to vital
organs such as the heart, brain, and kidneys.
 Without constant flow to these organs, death occurs within seconds, minutes, or days.
 Although a decrease in flow produces an immediate threat to life, the continuous
elevation of blood pressure that occurs with hypertension is a contributor to premature
death and disability due to its effect on the heart, blood vessels, and kidneys.
197
Control of Blood Pressure
 The arterial blood pressure reflects the rhythmic ejection of blood from the left
ventricle into the aorta.
 It rises as the left ventricle contracts and falls as it relaxes.
 In healthy adults, the highest pressure, called the systolic pressure, ideally is less than
120 mm Hg,
 and the lowest pressure, called the diastolic pressure, is less than 80 mm Hg.
 The difference between the systolic and diastolic pressure (approximately 40 mm Hg)
is the pulse pressure.
 The mean arterial pressure (approximately 90 to 100 mm Hg), represents the average
pressure in the arterial system during ventricular contraction and relaxation (Cardiac
Cycle)
 Mean arterial pressure = diastolic pressure + pulse pressure/3.
198
MAP Clinical significance
 MAP is a useful concept because it can be used to calculate overall blood flow, and thus
delivery of nutrients to the various organs. It is a good indicator of perfusion pressure
(ΔP) seen by organs in the body
 Perfusion is the process of nutritive delivery of arterial blood to a capillary bed in the
tissue.
 Tests of adequate perfusion are a part of the patient assessment process performed by
medical or emergency personnel.
 The most common methods include evaluating skin color, temperature, condition and
capillary refill.
 It is believed that a MAP that is greater than 60 mmHg is enough to sustain the organs
of the average person.
 If the MAP falls significantly below this number for an appreciable time, the end organ
will not get enough blood flow, and will become ischemic.
Determinants of Blood Pressure
 The systolic and diastolic components of blood pressure are determined by the cardiac
output and the peripheral vascular resistance.
 Cardiac output is the volume of blood pumped by the heart per minute (mL
blood/min).
 The stroke volume is the volume of blood, in milliliters (mL), pumped out of the heart
with each beat.
 The heart rate is simply the number of heart beats per minute.
 Increasing either stroke volume or heart rate increases cardiac output.
 Cardiac output of an adult male ranges from 4.5 to 8 L/minute.
 Cardiac Output in mL/min = Stroke volume (mL/beat) X Heart rate (beats/min)
 An average person has a resting heart rate of 70 beats/minute and a resting stroke
volume of 70 mL/beat.
 The cardiac output for this person at rest is:
 Cardiac Output = 70 (mL/beat) X 70 (beats/min) = 4900 mL/minute.
 The total volume of blood in the circulatory system of an average person is about 5
liters (5000 mL).
 According to our calculations, the entire volume of blood within the circulatory system is
pumped by the heart each minute (at rest).
199
 During vigorous exercise, the cardiac output can increase up to 7 fold (35
liters/minute).
Definition
 A systolic blood pressure ( SBP) >139 mmHg and/or
 A diastolic (DBP) >89 mmHg.
 Based on the average of two or more properly measured, seated BP readings.
 On each of two or more office visits.
The progression of essential hypertension is as follows:
1) Prehypertension in persons aged 10-30 years (by increased cardiac output)
2) Early hypertension in persons aged 20-40 years (in which increased peripheral
resistance is prominent)
3) Established hypertension in persons aged 30-50 years
4) Complicated hypertension in persons aged 40-60 years
200
Classification of Hypertension
 Primary (Essential) Hypertension
 No identifiable cause of hypertension, it is most often the result of complex
interactions between multiple genetic and environmental factors.
 The onset is usually between ages 25 and 55 years; it is uncommon before age 20
years.
 Secondary Hypertension
 Those previously well controlled who become refractory to treatment.
201
Cardiac output and peripheral resistance
 Maintenance of a normal blood pressure is dependent on the balance between the
cardiac output and peripheral vascular resistance.
 The hemodynamic hallmark of established essential hypertension is elevated
peripheral vascular resistance.
 An increase in cardiac output is occasionally noted early but is not a persistent
finding.
 Peripheral resistance is determined not by large arteries or the capillaries but by
small arterioles, the walls of which contain smooth muscle cells.
 Prolonged smooth muscle constriction is thought to induce structural changes with
thickening of the arteriolar vessel walls possibly mediated by angiotensin, leading to
an irreversible rise in peripheral resistance.
202
Mechanisms of Hypertension
The pathogenesis of essential hypertension is multifactorial and highly complex
203
Causes of Hypertension
 Primary– 90-95% of cases – also termed “essential” or “idiopathic”
 Secondary – about 5% of cases
 Renal parenchymal 2-3%
 Renovascular disease 1-2%
 Endocrine disease 0.3-1%
o Pheochromocytoma
o Cushings syndrome
o Conn’s syndrome (Primary Hyperaldosteronism)
o Acromegaly and hypothyroidism
 Vascular
o Coarctation of the aorta
o Nonspecific aortoarteritis
 Iatrogenic 0.50%
o hypertension associated with pregnancy,
o Hormonal / oral contraceptive
o Hypercalcemia (may be caused by renal insufficiency, calcium-mediated
vasoconstriction, or both).
o Medications (NSAIDs)
Other Patterns of Hypertension
 White coat or office hypertension may account for as many as 20% of elevated blood
pressures and is associated with an increased cardiovascular risk.
 Isolated systolic hypertension (ISH), defined as a systolic blood pressure >160 mm Hg
and a diastolic blood pressure >90 mm Hg, is a far greater risk factor for the
development of cardiovascular disease than is the diastolic blood pressure.
 The systolic blood pressure increases in a linear fashion throughout life, whereas, the
diastolic blood pressure increases until 50 years of age and falls thereafter.
 This phenomenon is thought to reflect a gradual decrease in arterial compliance
(elasticity) over time (due to remodeling and calcification of the vessel wall).
204
 The decrease in compliance with age and menopause. causes an increase in blood
pressure during systole and a decrease during diastole (because of loss of the elastic
recoil which augments pressure during diastole).
 Because a decrease in compliance in the vessel is related to vascular remodeling and
calcification, ISH is a de facto clinical marker of injury in the vessel wall.
Secondary Hypertension
1) Renovascular disease (Renal artery stenosis)
 Renal artery disease can cause of narrowing of the vessel lumen (stenosis). This
stenosis reduces the pressure at the afferent arteriole in the kidney. Reduced arteriolar
pressure and reduced renal perfusion stimulate Renin release by the kidney.
 This increases circulating angiotensin II (AII) and aldosterone. These hormones
increase blood volume by enhancing renal reabsorption of sodium and water.
 Increased AII causes systemic vasoconstriction and enhances sympathetic activity.
 Chronic elevation of AII promotes cardiac and vascular hypertrophy.
 The net effect of these renal mechanisms is an increase in blood volume that
augments cardiac output by the Frank-Starling mechanism.
 Therefore, hypertension caused by renal artery stenosis results from both an increase
in systemic vascular resistance and an increase in cardiac output.
2) Chronic renal disease
 Diabetic nephropathy or Glomerulonephritis can damage nephrons in the kidney.
 When this occurs, the kidney cannot excrete normal amounts of sodium which leads
to sodium and water retention, increased blood volume, and increased cardiac output
by the Frank-Starling mechanism. Renal disease may also result in increased release
of renin leading to a renin-dependent form of hypertension.
 The elevation in arterial pressure secondary to renal disease can be viewed as an
attempt by the kidney to increase renal perfusion and restore glomerular filtration.
3) Secondary Hypertension (Endocrine)
 Pheochromocytoma is a rare (2 to 8 cases per 1 million persons per year)
 adrenaline-producing tumor that arises from the Adrenal medulla. High levels of
Catecholamines (Norepinephrine). <0.2% of cases of hypertension; all ages ,mainly
30-50 years.
 Headaches, Palpitations, Diaphoresis, Severe hypertension
 Cushing's syndrome is a collection of symptoms that develop due to very high levels
of cortisol hormone.
 Conn syndrome (Primary aldosteronism): HTN, Low K, caused by aldosterone-
producing adenoma (80% of cases) usually unilateral and solitary.
205
4) Vascular Hypertension: Coarctation of the aorta
 It is a congenital condition whereby the aorta narrows in the area where the ductus
arteriosus (ligamentum arteriosum after regression) inserts.
 The word “coarctation” means narrowing.
206
Patent ductus arteriosus
 In the developing fetus, the mother provides oxygen and the baby's lungs are filled with
fluid.
 Blood flow bypasses the lungs through a blood vessel that connects the pulmonary artery
(1) with the aorta (2). This blood vessel is called the ductus arteriosus (3).
 When the lungs inflate at birth, blood flows through the pulmonary vessels and the ductus
arteriosus occludes.
 When it remains open after birth it is called a patent ductus arteriosus. In most babies
it remains open for a short period of time after birth but 90% will be closed by 8 weeks of
age. Most of the rest will close during the first year of life.
 In about 1 of every 5500 births this duct fails to close properly and remains patent.
 The presence of this duct allows for the backflow of aortic blood into the pulmonary
artery. The turbulent blood flow can be detected on auscultation as a murmur.
 If not corrected, the continued pulmonary congestion places an excess workload on the
heart that can result in heart failure years later.
 Surgical correction of patent ductus arteriosus is relatively simple and essentially
involves ligation of the ductus arteriosus.
207
Physiological mechanisms involved in development of essential hypertension
1) Cardiac output } discussed before
2) Peripheral resistance } discussed before
3) Renin-angiotensin-aldosterone system
4) Autonomic nervous system
5) Other factors:(will be discussed by Endothelial dysfunction)
A. Bradykinin
B. Endothelin
C. EDRF (endothelial derived relaxing factor) or
D. Nitric Oxide
E. ANP (atrial natriuretic peptide)
F. Ouabain
208
3) Renin-Angiotensin-Aldosterone system (RAAS) Summary
Renin-angiotensin system (Detailed Figure)
209
 The renin-angiotensin system (RAS) or the renin-angiotensin-aldosterone system
(RAAS) is a hormone system that regulates blood pressure and water (fluid) balance.
 When blood volume is low, the kidneys secrete an enzyme called renin.
 Renin stimulates the production of angiotensin.
 Angiotensin causes blood vessels to constrict resulting in increased blood pressure.
 Angiotensin also stimulates the secretion of the hormone aldosterone from the
adrenal cortex.
 Aldosterone causes the tubules of the kidneys to increase the reabsorption of sodium
and water.
 This increases the volume of fluid in the body, which also increases blood pressure.
 If the renin-angiotensin-aldosterone system is too active, blood pressure will be too
high.
 The system can be activated when there is a loss of blood volume or a drop in blood
pressure (such as in hemorrhage).
 If the perfusion of the juxtaglomerular apparatus in the kidney's macula densa
decreases, then the juxtaglomerular cells release the enzyme renin.
 Inhibitors of angiotensin-converting enzyme (ACE inhibitors) are often used to
reduce the formation of the more potent angiotensin II. Captopril is an example of an
ACE inhibitor.
 Alternatively, angiotensin receptor blockers (ARBs) can be used to prevent
angiotensin II from acting on angiotensin receptors.
 Direct renin inhibitors are aliskiren
4) Autonomic nervous system
 Sympathetic nervous system (which is a part of autonomic nervous system)
stimulation can cause both arteriolar constriction and arteriolar dilatation.
 Thus it has an important role in maintaining a normal blood pressure.
 It is also important in the mediation of short term changes in blood pressure in
response to stress and physical exercise.
 Autonomic nervous system: A part of the nervous system that regulates key
involuntary functions of the body, including the activity of the heart muscle; the
smooth muscles, including the muscles of the intestinal tract; and the glands
(breathing, the heartbeat, and digestive processes)
210
5) Endothelium
 The endothelium is the inner lining of the arterial wall that comes in direct contact
with the blood.
 It is composed of a single layer of simple squamous lining cells and polygonal in
shape.
 A healthy endothelial protects against atherosclerosis.
 Nitrite oxide causes the blood vessels to dilate in order to increase blood flow.
Abnormal endothelial function causes a reduction in the secretion of nitric oxide.
Lack of nitrite oxide causes the blood vessels to constrict instead.
Endothelial Function
 The healthy endothelium is optimally placed and is able to respond to physical and
chemical signals by production of a wide range of factors that regulate vascular tone,
cellular adhesion, thromboresistance, smooth muscle cell proliferation, and vessel
wall inflammation.
 A healthy endothelium maintains a balance between all these different forces. It is
normal to have a certain level of constriction, of inflammation, but it should be in
balance with all the other functions.
 Endothelial dysfunction defined as an imbalance between vasodilating and
vasoconstricting substances produced by (or acting on) the endothelium. It may be
the result of an injury from high blood glucose, high blood pressure, high cholesterol,
smoking, or those cytokines and substances released from visceral fat.
211
212
Endothelial Vasoactive Substances
Vascular endothelial cells play a key role in cardiovascular regulation by producing a
number of potent local Vasoactive Substances:
 Bradykinin is a potent endothelium-dependent vasodilator, leading to a drop in blood
pressure.
o It also causes contraction of non-vascular smooth muscle in the bronchus and
gut, increases vascular permeability.
o Bradykinin also causes natriuresis (excretion of sodium in the urine),
contributing to the drop in blood pressure.
o Bradykinin is also thought to be the cause of the dry cough in some patients
on angiotensin-converting enzyme (ACE) inhibitor drugs.
o It is thought that bradykinin is converted to inactive metabolites by ACE,
therefore inhibition of this enzyme leads to increased levels of bradykinin,
which causes a dry cough via bronchoconstriction.
 Endothelin is a powerful, vascular, endothelial vasoconstrictor, which may produce
a salt sensitive rise in blood pressure. It also activates local rennin angiotensin
systems.
 Endothelial derived relaxant factor (EDRF) or Nitric Oxide (NO), is produced by
arterial and venous endothelium and diffuses through the vessel wall into the smooth
muscle causing vasodilatation
 Atrial natriuretic peptide is a hormone secreted from the atria of the heart in
response to increased blood volume.
o Its effect is to increase sodium and water excretion from the kidney as a sort of
natural diuretic.
o A defect in this system may cause fluid retention and hypertension.
o Sodium transport across vascular smooth muscle cell walls is also thought to
influence blood pressure via its interrelation with calcium transport.
 Ouabain may be a naturally occurring steroid›like substance which is thought to
interfere with cell sodium and calcium transport, giving rise to vasoconstriction.
213
Endothelium-Derived Contracting Factors (EDCFs) include endothelin-1, angiotensin II,
thromboxane A2 (TxA2), prostaglandin H2, and reactive oxygen species (ROS).
HTN Risk Factors
 Although the cause or causes of essential hypertension are largely unknown, several
constitutional factors have been implicated as contributing to its development.
 These risk factors include family history of hypertension, race, diabetes mellitus, and
age-related increases in blood pressure.
 Hypertension not only is more prevalent in African Americans than whites, it is more
severe, tends to occur earlier, and often is not treated early enough or aggressively
enough. Blacks also tend to develop greater cardiovascular and renal damage at any level
of pressure.
 Diabetes mellitus and hypertension are closely interrelated disorders that share similar
genetic and life-style factors.
 Lifestyle Factors: These lifestyle factors include high sodium intake, excessive calorie
intake and obesity, physical inactivity, and excessive alcohol consumption.
 Oral contraceptive drugs also may increase blood pressure in predisposed women.
214
 Although stress can raise blood pressure acutely, there is less evidence linking it to
chronic elevations in blood pressure.
 Dietary fats and cholesterol are independent risk factors for cardiovascular disease, but
there is no evidence that they raise blood pressure.
 Smoking, although not identified as a primary risk factor in hypertension, is an
independent risk factor in coronary heart disease and should be avoided.
Manifestations of Hypertension
 Essential hypertension is typically an asymptomatic disorder.
 When symptoms do occur they are usually related to the long- term effects of
hypertension on other organ systems of the body including the kidneys, heart, eyes, and
blood vessels.
 Diastolic blood pressure is the best predictor of cardiovascular disease in young people.
 Systolic blood pressure is the dominant predictor of risk of cardiovascular disease in
older people
215
Hypotension
 Hypotension is an abnormally low blood pressure.
 One common form of hypotension is orthostatic hypotension (also called postural
hypotension) that occurs upon standing.
 Orthostatic hypotension is a systolic blood pressure decrease of at least 20 mm Hg or a
diastolic blood pressure decrease of at least 10 mm Hg within three minutes of standing.
 In healthy persons, muscle contraction increases venous return of blood to the heart
through one-way valves that prevent blood from pooling in dependent parts of the body.
 The autonomic nervous system responds to changes in position by constricting veins and
arteries and increasing heart rate and cardiac contractility.
 When these mechanisms are faulty or if the patient is hypovolemic, orthostatic
hypotension may occur.
 More common in: Elderly pts with systolic HTN , DM, Pts on diuretics, vasodilators, or
some psychotropic drugs
 In persons with orthostatic hypotension, gravitational opposition to venous return causes
a decrease in blood pressure and threatens cerebral ischemia.
Causes of Orthostatic Hypotension
1) Aging — Associated with reduced baroreceptor responses, decreased cardiac output and
reduced vascular responsiveness
2) Decreased blood or fluid volume — Caused by dehydration, diarrhea, diuretic use
3) Autonomic nervous defects — An inability to initiate vasoconstriction and increased
heart rate reflexes
4) Prolonged bed rest — Associated with reduced plasma volume, decreased vascular tone
5) Drug-induced — Examples: antihypertensive drugs, calcium channel blockers,
vasodilators
6) Idiopathic — Cause is not known
Orthostatic hypotension
 Manifestations
 Dizziness (syncopy)
 Decreased cardiac output
 Reduced brain blood flow
216
 Pooling of blood in the extremities
 Falls and injuries, particularly in elderly individuals
 Treatment
 Maintain fluid volume.
 If patient is lying down, have the patient first sit for several minutes to allow blood
pressure to equilibrate, then have patient stand slowly.
 Provide elastic support garments and stockings that may help prevent pooling of blood in
the lower extremities.
--------------------------------
217

More Related Content

What's hot

Secondary hypertension - Etiopathogenesis, Clinical features, Advances in Man...
Secondary hypertension - Etiopathogenesis, Clinical features, Advances in Man...Secondary hypertension - Etiopathogenesis, Clinical features, Advances in Man...
Secondary hypertension - Etiopathogenesis, Clinical features, Advances in Man...
Chetan Ganteppanavar
 
Cardiac biomarkers - II
Cardiac biomarkers  - IICardiac biomarkers  - II
Cardiac biomarkers - II
Hussein Al-tameemi
 
Pathophysiology of hypertension
Pathophysiology of hypertensionPathophysiology of hypertension
Pathophysiology of hypertension
Anusha Rameshwaram
 
Arterial hypertension pratyasha paripurna
Arterial hypertension pratyasha paripurnaArterial hypertension pratyasha paripurna
Arterial hypertension pratyasha paripurna
ParipurnaPradhan
 
Cardiac biomarkers
Cardiac biomarkersCardiac biomarkers
Cardiac biomarkers
Jai Kanth
 
Chronic stable angina
Chronic stable anginaChronic stable angina
Chronic stable anginaMuhammad Saim
 
Pathology of Hypertension
Pathology of HypertensionPathology of Hypertension
Pathology of Hypertension
Darya Daoud
 
Cardiac markers
Cardiac markersCardiac markers
Cardiac markers
binaya tamang
 
Hypertension
HypertensionHypertension
Hypertension
asadullah ansari
 
Arrhythmias
ArrhythmiasArrhythmias
Arrhythmias
Swatilekha Das
 
Pericardial diseases
Pericardial  diseasesPericardial  diseases
Pericardial diseases
ikramdr01
 
Hypertension presentation
Hypertension presentationHypertension presentation
Hypertension presentation
MinhajulislamSiam2
 
Heart Murmur
Heart MurmurHeart Murmur
Heart Murmur
Ma Wady
 
Hypertension
HypertensionHypertension
Hypertension
hawraz Faris
 
Hypertension
HypertensionHypertension
Hypertension
HypertensionHypertension
Hypertension
NedaFatima4
 

What's hot (20)

Secondary hypertension - Etiopathogenesis, Clinical features, Advances in Man...
Secondary hypertension - Etiopathogenesis, Clinical features, Advances in Man...Secondary hypertension - Etiopathogenesis, Clinical features, Advances in Man...
Secondary hypertension - Etiopathogenesis, Clinical features, Advances in Man...
 
Cardiac biomarkers - II
Cardiac biomarkers  - IICardiac biomarkers  - II
Cardiac biomarkers - II
 
Pathophysiology of hypertension
Pathophysiology of hypertensionPathophysiology of hypertension
Pathophysiology of hypertension
 
Hypertension
HypertensionHypertension
Hypertension
 
Hypertension
HypertensionHypertension
Hypertension
 
Arterial hypertension pratyasha paripurna
Arterial hypertension pratyasha paripurnaArterial hypertension pratyasha paripurna
Arterial hypertension pratyasha paripurna
 
Hypertension
HypertensionHypertension
Hypertension
 
Cardiac biomarkers
Cardiac biomarkersCardiac biomarkers
Cardiac biomarkers
 
Chronic stable angina
Chronic stable anginaChronic stable angina
Chronic stable angina
 
Pathology of Hypertension
Pathology of HypertensionPathology of Hypertension
Pathology of Hypertension
 
Cardiac markers
Cardiac markersCardiac markers
Cardiac markers
 
Hypertension
HypertensionHypertension
Hypertension
 
Arrhythmias
ArrhythmiasArrhythmias
Arrhythmias
 
Pericardial diseases
Pericardial  diseasesPericardial  diseases
Pericardial diseases
 
Hypertension presentation
Hypertension presentationHypertension presentation
Hypertension presentation
 
Bradycardia
BradycardiaBradycardia
Bradycardia
 
Heart Murmur
Heart MurmurHeart Murmur
Heart Murmur
 
Hypertension
HypertensionHypertension
Hypertension
 
Hypertension
HypertensionHypertension
Hypertension
 
Hypertension
HypertensionHypertension
Hypertension
 

Viewers also liked

Hypertension 2013 Pathophysiology
Hypertension 2013 PathophysiologyHypertension 2013 Pathophysiology
Hypertension 2013 PathophysiologyGunter Hennersdorf
 
Pathophysiology hypertension.
Pathophysiology hypertension.Pathophysiology hypertension.
Pathophysiology hypertension.Shaikhani.
 
Slideshow
SlideshowSlideshow
Slideshowhome
 
heart cardiac cycle
heart cardiac cycleheart cardiac cycle
heart cardiac cycle
sydpeck93
 
Hypertension in Pregnancy
Hypertension  in  PregnancyHypertension  in  Pregnancy
Hypertension in Pregnancy
sosojammoly
 
Endothelial Dysfunction Y O U S R Y Y Yeasured
Endothelial  Dysfunction   Y O U S R Y Y YeasuredEndothelial  Dysfunction   Y O U S R Y Y Yeasured
Endothelial Dysfunction Y O U S R Y Y Yeasured
M.YOUSRY Abdel-Mawla
 
Lecture 18 Hepatitis and liver disorders
Lecture 18 Hepatitis and liver disordersLecture 18 Hepatitis and liver disorders
Lecture 18 Hepatitis and liver disorders
Areej Abu Hanieh
 
Lecture 15 kidney- pathology
Lecture 15 kidney- pathology Lecture 15 kidney- pathology
Lecture 15 kidney- pathology
Areej Abu Hanieh
 
Pathology - Cancer
Pathology - CancerPathology - Cancer
Pathology - Cancer
Areej Abu Hanieh
 
Lecture 20 disorders of hypothalamus, pituitary and thyroid glands - Pathology
Lecture 20 disorders of hypothalamus, pituitary and thyroid glands - PathologyLecture 20 disorders of hypothalamus, pituitary and thyroid glands - Pathology
Lecture 20 disorders of hypothalamus, pituitary and thyroid glands - Pathology
Areej Abu Hanieh
 
Lecture 22 diabetes mellitus - pathology
Lecture 22 diabetes mellitus - pathologyLecture 22 diabetes mellitus - pathology
Lecture 22 diabetes mellitus - pathology
Areej Abu Hanieh
 
Lecture 7 diseases of the vascular system - Pathology
Lecture 7 diseases of the vascular system - Pathology Lecture 7 diseases of the vascular system - Pathology
Lecture 7 diseases of the vascular system - Pathology
Areej Abu Hanieh
 
Pathology - Cell Injury
Pathology - Cell Injury Pathology - Cell Injury
Pathology - Cell Injury
Areej Abu Hanieh
 
Endothelin
EndothelinEndothelin
Endothelin
Jitendra Agrawal
 
Lecture 10 valvular heart disease - Pathology
Lecture 10 valvular heart disease - Pathology Lecture 10 valvular heart disease - Pathology
Lecture 10 valvular heart disease - Pathology
Areej Abu Hanieh
 
Lecture 19 pancreatitis - Pathology
Lecture 19 pancreatitis - PathologyLecture 19 pancreatitis - Pathology
Lecture 19 pancreatitis - Pathology
Areej Abu Hanieh
 
Pathology - HIV (AIDS)
Pathology - HIV (AIDS)Pathology - HIV (AIDS)
Pathology - HIV (AIDS)
Areej Abu Hanieh
 
pathology - Hematology
pathology - Hematology pathology - Hematology
pathology - Hematology
Areej Abu Hanieh
 
2012 4-16 renal physiology
2012 4-16 renal physiology2012 4-16 renal physiology
2012 4-16 renal physiologyHannusiya
 

Viewers also liked (20)

Hypertension 2013 Pathophysiology
Hypertension 2013 PathophysiologyHypertension 2013 Pathophysiology
Hypertension 2013 Pathophysiology
 
Pathophysiology hypertension.
Pathophysiology hypertension.Pathophysiology hypertension.
Pathophysiology hypertension.
 
Slideshow
SlideshowSlideshow
Slideshow
 
heart cardiac cycle
heart cardiac cycleheart cardiac cycle
heart cardiac cycle
 
Hypertension in Pregnancy
Hypertension  in  PregnancyHypertension  in  Pregnancy
Hypertension in Pregnancy
 
Endothelial Dysfunction Y O U S R Y Y Yeasured
Endothelial  Dysfunction   Y O U S R Y Y YeasuredEndothelial  Dysfunction   Y O U S R Y Y Yeasured
Endothelial Dysfunction Y O U S R Y Y Yeasured
 
Endothelin ppt
Endothelin ppt Endothelin ppt
Endothelin ppt
 
Lecture 18 Hepatitis and liver disorders
Lecture 18 Hepatitis and liver disordersLecture 18 Hepatitis and liver disorders
Lecture 18 Hepatitis and liver disorders
 
Lecture 15 kidney- pathology
Lecture 15 kidney- pathology Lecture 15 kidney- pathology
Lecture 15 kidney- pathology
 
Pathology - Cancer
Pathology - CancerPathology - Cancer
Pathology - Cancer
 
Lecture 20 disorders of hypothalamus, pituitary and thyroid glands - Pathology
Lecture 20 disorders of hypothalamus, pituitary and thyroid glands - PathologyLecture 20 disorders of hypothalamus, pituitary and thyroid glands - Pathology
Lecture 20 disorders of hypothalamus, pituitary and thyroid glands - Pathology
 
Lecture 22 diabetes mellitus - pathology
Lecture 22 diabetes mellitus - pathologyLecture 22 diabetes mellitus - pathology
Lecture 22 diabetes mellitus - pathology
 
Lecture 7 diseases of the vascular system - Pathology
Lecture 7 diseases of the vascular system - Pathology Lecture 7 diseases of the vascular system - Pathology
Lecture 7 diseases of the vascular system - Pathology
 
Pathology - Cell Injury
Pathology - Cell Injury Pathology - Cell Injury
Pathology - Cell Injury
 
Endothelin
EndothelinEndothelin
Endothelin
 
Lecture 10 valvular heart disease - Pathology
Lecture 10 valvular heart disease - Pathology Lecture 10 valvular heart disease - Pathology
Lecture 10 valvular heart disease - Pathology
 
Lecture 19 pancreatitis - Pathology
Lecture 19 pancreatitis - PathologyLecture 19 pancreatitis - Pathology
Lecture 19 pancreatitis - Pathology
 
Pathology - HIV (AIDS)
Pathology - HIV (AIDS)Pathology - HIV (AIDS)
Pathology - HIV (AIDS)
 
pathology - Hematology
pathology - Hematology pathology - Hematology
pathology - Hematology
 
2012 4-16 renal physiology
2012 4-16 renal physiology2012 4-16 renal physiology
2012 4-16 renal physiology
 

Similar to Lecture 8 hypertension - Pathology

Unit 1_Understanding HTN(1).pptx
Unit 1_Understanding HTN(1).pptxUnit 1_Understanding HTN(1).pptx
Unit 1_Understanding HTN(1).pptx
ImanuIliyas
 
Blood pressure regulation
Blood pressure regulationBlood pressure regulation
Blood pressure regulation
NAKULBK1
 
L5 &amp; 6 effects of htn on vessels &amp; heart 20 (2)
L5 &amp; 6 effects of htn on vessels &amp; heart 20 (2)L5 &amp; 6 effects of htn on vessels &amp; heart 20 (2)
L5 &amp; 6 effects of htn on vessels &amp; heart 20 (2)
imrana tanvir
 
Heart disorders
Heart disordersHeart disorders
Heart disorders
pankaj kushwaha
 
Hypertension Congestive Heart Failure Pharmacology Talk Part 1
Hypertension Congestive Heart Failure Pharmacology Talk Part 1Hypertension Congestive Heart Failure Pharmacology Talk Part 1
Hypertension Congestive Heart Failure Pharmacology Talk Part 1kenna518
 
Hypertension
HypertensionHypertension
Hypertension
ligi xavier
 
Determinants of cardiac output for captivate
Determinants of cardiac output for captivateDeterminants of cardiac output for captivate
Determinants of cardiac output for captivateleslielally
 
Hypertension presentation
Hypertension presentationHypertension presentation
Hypertension presentationTeketel23
 
Hypertension
HypertensionHypertension
Hypertension
Nandkishor Jha
 
HTN CRISIS SEMINER.pptx
HTN CRISIS SEMINER.pptxHTN CRISIS SEMINER.pptx
HTN CRISIS SEMINER.pptx
ImanuIliyas
 
hypertension.docx
hypertension.docxhypertension.docx
hypertension.docx
ssuser7413b8
 
Cardiac Range.ppt
Cardiac Range.pptCardiac Range.ppt
Cardiac Range.ppt
Ogunsina1
 
Blood pressure and its regulation .
Blood pressure and its regulation . Blood pressure and its regulation .
Blood pressure and its regulation .
Karishma Shaw
 
Hypertention ppt
Hypertention pptHypertention ppt
Hypertention ppt
Neelam Yadav
 
Basic science and forensic pathology aspects of Hypertensive cardiovascular d...
Basic science and forensic pathology aspects of Hypertensive cardiovascular d...Basic science and forensic pathology aspects of Hypertensive cardiovascular d...
Basic science and forensic pathology aspects of Hypertensive cardiovascular d...
Luchengam
 
HYPERTENSION
HYPERTENSIONHYPERTENSION
HYPERTENSION
leekay13
 
1. Hypertension (2).pptx
1. Hypertension (2).pptx1. Hypertension (2).pptx
1. Hypertension (2).pptx
samsonkiflu
 
PATHOLOGY OF HYPERTENSION .ppt
PATHOLOGY OF HYPERTENSION           .pptPATHOLOGY OF HYPERTENSION           .ppt
PATHOLOGY OF HYPERTENSION .ppt
Imtiyaz60
 

Similar to Lecture 8 hypertension - Pathology (20)

Unit 1_Understanding HTN(1).pptx
Unit 1_Understanding HTN(1).pptxUnit 1_Understanding HTN(1).pptx
Unit 1_Understanding HTN(1).pptx
 
Blood pressure regulation
Blood pressure regulationBlood pressure regulation
Blood pressure regulation
 
L5 &amp; 6 effects of htn on vessels &amp; heart 20 (2)
L5 &amp; 6 effects of htn on vessels &amp; heart 20 (2)L5 &amp; 6 effects of htn on vessels &amp; heart 20 (2)
L5 &amp; 6 effects of htn on vessels &amp; heart 20 (2)
 
Heart disorders
Heart disordersHeart disorders
Heart disorders
 
10 hypertension
10 hypertension10 hypertension
10 hypertension
 
Hypertension Congestive Heart Failure Pharmacology Talk Part 1
Hypertension Congestive Heart Failure Pharmacology Talk Part 1Hypertension Congestive Heart Failure Pharmacology Talk Part 1
Hypertension Congestive Heart Failure Pharmacology Talk Part 1
 
Hypertension
HypertensionHypertension
Hypertension
 
Determinants of cardiac output for captivate
Determinants of cardiac output for captivateDeterminants of cardiac output for captivate
Determinants of cardiac output for captivate
 
Hypertension presentation
Hypertension presentationHypertension presentation
Hypertension presentation
 
Samir rafla principles of cardiology pages 62 86
Samir rafla principles of cardiology pages 62 86Samir rafla principles of cardiology pages 62 86
Samir rafla principles of cardiology pages 62 86
 
Hypertension
HypertensionHypertension
Hypertension
 
HTN CRISIS SEMINER.pptx
HTN CRISIS SEMINER.pptxHTN CRISIS SEMINER.pptx
HTN CRISIS SEMINER.pptx
 
hypertension.docx
hypertension.docxhypertension.docx
hypertension.docx
 
Cardiac Range.ppt
Cardiac Range.pptCardiac Range.ppt
Cardiac Range.ppt
 
Blood pressure and its regulation .
Blood pressure and its regulation . Blood pressure and its regulation .
Blood pressure and its regulation .
 
Hypertention ppt
Hypertention pptHypertention ppt
Hypertention ppt
 
Basic science and forensic pathology aspects of Hypertensive cardiovascular d...
Basic science and forensic pathology aspects of Hypertensive cardiovascular d...Basic science and forensic pathology aspects of Hypertensive cardiovascular d...
Basic science and forensic pathology aspects of Hypertensive cardiovascular d...
 
HYPERTENSION
HYPERTENSIONHYPERTENSION
HYPERTENSION
 
1. Hypertension (2).pptx
1. Hypertension (2).pptx1. Hypertension (2).pptx
1. Hypertension (2).pptx
 
PATHOLOGY OF HYPERTENSION .ppt
PATHOLOGY OF HYPERTENSION           .pptPATHOLOGY OF HYPERTENSION           .ppt
PATHOLOGY OF HYPERTENSION .ppt
 

More from Areej Abu Hanieh

Announcement about my previous presentations - Thank you
Announcement about my previous presentations - Thank youAnnouncement about my previous presentations - Thank you
Announcement about my previous presentations - Thank you
Areej Abu Hanieh
 
Infection - penicillins
Infection - penicillinsInfection - penicillins
Infection - penicillins
Areej Abu Hanieh
 
Hospital acquired pneumonia
Hospital acquired pneumoniaHospital acquired pneumonia
Hospital acquired pneumonia
Areej Abu Hanieh
 
catheter related blood stream infection
catheter related blood stream infection catheter related blood stream infection
catheter related blood stream infection
Areej Abu Hanieh
 
Community acquired pneumonia - Pharmacotherapy
Community acquired pneumonia - Pharmacotherapy Community acquired pneumonia - Pharmacotherapy
Community acquired pneumonia - Pharmacotherapy
Areej Abu Hanieh
 
Cellulitis - Treatment
Cellulitis - TreatmentCellulitis - Treatment
Cellulitis - Treatment
Areej Abu Hanieh
 
Carbapenems - Pharmacology
Carbapenems - PharmacologyCarbapenems - Pharmacology
Carbapenems - Pharmacology
Areej Abu Hanieh
 
Cephalosporins - Pharmacology
Cephalosporins - Pharmacology Cephalosporins - Pharmacology
Cephalosporins - Pharmacology
Areej Abu Hanieh
 
Sickle cell anemia
Sickle cell anemia Sickle cell anemia
Sickle cell anemia
Areej Abu Hanieh
 
Poisoning - Treatment
Poisoning - TreatmentPoisoning - Treatment
Poisoning - Treatment
Areej Abu Hanieh
 
Hypertensive urgencies and emergencies
Hypertensive urgencies and emergenciesHypertensive urgencies and emergencies
Hypertensive urgencies and emergencies
Areej Abu Hanieh
 
Diabetic ketoacidosis DKA
Diabetic ketoacidosis DKADiabetic ketoacidosis DKA
Diabetic ketoacidosis DKA
Areej Abu Hanieh
 
Asthma and COPD exacerbation - Emergency
Asthma and COPD exacerbation - Emergency  Asthma and COPD exacerbation - Emergency
Asthma and COPD exacerbation - Emergency
Areej Abu Hanieh
 
Acute decompensated heart failure
Acute decompensated heart failureAcute decompensated heart failure
Acute decompensated heart failure
Areej Abu Hanieh
 
Acute Coronary syndrome
Acute Coronary syndrome Acute Coronary syndrome
Acute Coronary syndrome
Areej Abu Hanieh
 
Glycemic Control - Diabetes Mellitus
Glycemic Control - Diabetes Mellitus Glycemic Control - Diabetes Mellitus
Glycemic Control - Diabetes Mellitus
Areej Abu Hanieh
 
Stress ulcer prophylaxis
Stress ulcer prophylaxis Stress ulcer prophylaxis
Stress ulcer prophylaxis
Areej Abu Hanieh
 
Pain in the ICU
Pain in the ICUPain in the ICU
Pain in the ICU
Areej Abu Hanieh
 
Deep Vein Thrombosis - DVT
Deep Vein Thrombosis  - DVTDeep Vein Thrombosis  - DVT
Deep Vein Thrombosis - DVT
Areej Abu Hanieh
 
Anti - Coagulants agents
Anti - Coagulants agentsAnti - Coagulants agents
Anti - Coagulants agents
Areej Abu Hanieh
 

More from Areej Abu Hanieh (20)

Announcement about my previous presentations - Thank you
Announcement about my previous presentations - Thank youAnnouncement about my previous presentations - Thank you
Announcement about my previous presentations - Thank you
 
Infection - penicillins
Infection - penicillinsInfection - penicillins
Infection - penicillins
 
Hospital acquired pneumonia
Hospital acquired pneumoniaHospital acquired pneumonia
Hospital acquired pneumonia
 
catheter related blood stream infection
catheter related blood stream infection catheter related blood stream infection
catheter related blood stream infection
 
Community acquired pneumonia - Pharmacotherapy
Community acquired pneumonia - Pharmacotherapy Community acquired pneumonia - Pharmacotherapy
Community acquired pneumonia - Pharmacotherapy
 
Cellulitis - Treatment
Cellulitis - TreatmentCellulitis - Treatment
Cellulitis - Treatment
 
Carbapenems - Pharmacology
Carbapenems - PharmacologyCarbapenems - Pharmacology
Carbapenems - Pharmacology
 
Cephalosporins - Pharmacology
Cephalosporins - Pharmacology Cephalosporins - Pharmacology
Cephalosporins - Pharmacology
 
Sickle cell anemia
Sickle cell anemia Sickle cell anemia
Sickle cell anemia
 
Poisoning - Treatment
Poisoning - TreatmentPoisoning - Treatment
Poisoning - Treatment
 
Hypertensive urgencies and emergencies
Hypertensive urgencies and emergenciesHypertensive urgencies and emergencies
Hypertensive urgencies and emergencies
 
Diabetic ketoacidosis DKA
Diabetic ketoacidosis DKADiabetic ketoacidosis DKA
Diabetic ketoacidosis DKA
 
Asthma and COPD exacerbation - Emergency
Asthma and COPD exacerbation - Emergency  Asthma and COPD exacerbation - Emergency
Asthma and COPD exacerbation - Emergency
 
Acute decompensated heart failure
Acute decompensated heart failureAcute decompensated heart failure
Acute decompensated heart failure
 
Acute Coronary syndrome
Acute Coronary syndrome Acute Coronary syndrome
Acute Coronary syndrome
 
Glycemic Control - Diabetes Mellitus
Glycemic Control - Diabetes Mellitus Glycemic Control - Diabetes Mellitus
Glycemic Control - Diabetes Mellitus
 
Stress ulcer prophylaxis
Stress ulcer prophylaxis Stress ulcer prophylaxis
Stress ulcer prophylaxis
 
Pain in the ICU
Pain in the ICUPain in the ICU
Pain in the ICU
 
Deep Vein Thrombosis - DVT
Deep Vein Thrombosis  - DVTDeep Vein Thrombosis  - DVT
Deep Vein Thrombosis - DVT
 
Anti - Coagulants agents
Anti - Coagulants agentsAnti - Coagulants agents
Anti - Coagulants agents
 

Recently uploaded

Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
Rohit chaurpagar
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Dr KHALID B.M
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
DrSathishMS1
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
Catherine Liao
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 

Recently uploaded (20)

Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 

Lecture 8 hypertension - Pathology

  • 1. Hypertension Lecture 8 Problem Magnitude  Hypertension (HTN) is the most common primary diagnosis in America.  35 million office visits are as the primary diagnosis of HTN.  50 million or more Americans have high BP.  Worldwide prevalence estimates for HTN may be as much as 1 billion.  7.1 million deaths per year may be attributable to hypertension. Hypertension  The purpose of the control of blood pressure is to keep blood flow constant to vital organs such as the heart, brain, and kidneys.  Without constant flow to these organs, death occurs within seconds, minutes, or days.  Although a decrease in flow produces an immediate threat to life, the continuous elevation of blood pressure that occurs with hypertension is a contributor to premature death and disability due to its effect on the heart, blood vessels, and kidneys. 197
  • 2. Control of Blood Pressure  The arterial blood pressure reflects the rhythmic ejection of blood from the left ventricle into the aorta.  It rises as the left ventricle contracts and falls as it relaxes.  In healthy adults, the highest pressure, called the systolic pressure, ideally is less than 120 mm Hg,  and the lowest pressure, called the diastolic pressure, is less than 80 mm Hg.  The difference between the systolic and diastolic pressure (approximately 40 mm Hg) is the pulse pressure.  The mean arterial pressure (approximately 90 to 100 mm Hg), represents the average pressure in the arterial system during ventricular contraction and relaxation (Cardiac Cycle)  Mean arterial pressure = diastolic pressure + pulse pressure/3. 198
  • 3. MAP Clinical significance  MAP is a useful concept because it can be used to calculate overall blood flow, and thus delivery of nutrients to the various organs. It is a good indicator of perfusion pressure (ΔP) seen by organs in the body  Perfusion is the process of nutritive delivery of arterial blood to a capillary bed in the tissue.  Tests of adequate perfusion are a part of the patient assessment process performed by medical or emergency personnel.  The most common methods include evaluating skin color, temperature, condition and capillary refill.  It is believed that a MAP that is greater than 60 mmHg is enough to sustain the organs of the average person.  If the MAP falls significantly below this number for an appreciable time, the end organ will not get enough blood flow, and will become ischemic. Determinants of Blood Pressure  The systolic and diastolic components of blood pressure are determined by the cardiac output and the peripheral vascular resistance.  Cardiac output is the volume of blood pumped by the heart per minute (mL blood/min).  The stroke volume is the volume of blood, in milliliters (mL), pumped out of the heart with each beat.  The heart rate is simply the number of heart beats per minute.  Increasing either stroke volume or heart rate increases cardiac output.  Cardiac output of an adult male ranges from 4.5 to 8 L/minute.  Cardiac Output in mL/min = Stroke volume (mL/beat) X Heart rate (beats/min)  An average person has a resting heart rate of 70 beats/minute and a resting stroke volume of 70 mL/beat.  The cardiac output for this person at rest is:  Cardiac Output = 70 (mL/beat) X 70 (beats/min) = 4900 mL/minute.  The total volume of blood in the circulatory system of an average person is about 5 liters (5000 mL).  According to our calculations, the entire volume of blood within the circulatory system is pumped by the heart each minute (at rest). 199
  • 4.  During vigorous exercise, the cardiac output can increase up to 7 fold (35 liters/minute). Definition  A systolic blood pressure ( SBP) >139 mmHg and/or  A diastolic (DBP) >89 mmHg.  Based on the average of two or more properly measured, seated BP readings.  On each of two or more office visits. The progression of essential hypertension is as follows: 1) Prehypertension in persons aged 10-30 years (by increased cardiac output) 2) Early hypertension in persons aged 20-40 years (in which increased peripheral resistance is prominent) 3) Established hypertension in persons aged 30-50 years 4) Complicated hypertension in persons aged 40-60 years 200
  • 5. Classification of Hypertension  Primary (Essential) Hypertension  No identifiable cause of hypertension, it is most often the result of complex interactions between multiple genetic and environmental factors.  The onset is usually between ages 25 and 55 years; it is uncommon before age 20 years.  Secondary Hypertension  Those previously well controlled who become refractory to treatment. 201
  • 6. Cardiac output and peripheral resistance  Maintenance of a normal blood pressure is dependent on the balance between the cardiac output and peripheral vascular resistance.  The hemodynamic hallmark of established essential hypertension is elevated peripheral vascular resistance.  An increase in cardiac output is occasionally noted early but is not a persistent finding.  Peripheral resistance is determined not by large arteries or the capillaries but by small arterioles, the walls of which contain smooth muscle cells.  Prolonged smooth muscle constriction is thought to induce structural changes with thickening of the arteriolar vessel walls possibly mediated by angiotensin, leading to an irreversible rise in peripheral resistance. 202
  • 7. Mechanisms of Hypertension The pathogenesis of essential hypertension is multifactorial and highly complex 203
  • 8. Causes of Hypertension  Primary– 90-95% of cases – also termed “essential” or “idiopathic”  Secondary – about 5% of cases  Renal parenchymal 2-3%  Renovascular disease 1-2%  Endocrine disease 0.3-1% o Pheochromocytoma o Cushings syndrome o Conn’s syndrome (Primary Hyperaldosteronism) o Acromegaly and hypothyroidism  Vascular o Coarctation of the aorta o Nonspecific aortoarteritis  Iatrogenic 0.50% o hypertension associated with pregnancy, o Hormonal / oral contraceptive o Hypercalcemia (may be caused by renal insufficiency, calcium-mediated vasoconstriction, or both). o Medications (NSAIDs) Other Patterns of Hypertension  White coat or office hypertension may account for as many as 20% of elevated blood pressures and is associated with an increased cardiovascular risk.  Isolated systolic hypertension (ISH), defined as a systolic blood pressure >160 mm Hg and a diastolic blood pressure >90 mm Hg, is a far greater risk factor for the development of cardiovascular disease than is the diastolic blood pressure.  The systolic blood pressure increases in a linear fashion throughout life, whereas, the diastolic blood pressure increases until 50 years of age and falls thereafter.  This phenomenon is thought to reflect a gradual decrease in arterial compliance (elasticity) over time (due to remodeling and calcification of the vessel wall). 204
  • 9.  The decrease in compliance with age and menopause. causes an increase in blood pressure during systole and a decrease during diastole (because of loss of the elastic recoil which augments pressure during diastole).  Because a decrease in compliance in the vessel is related to vascular remodeling and calcification, ISH is a de facto clinical marker of injury in the vessel wall. Secondary Hypertension 1) Renovascular disease (Renal artery stenosis)  Renal artery disease can cause of narrowing of the vessel lumen (stenosis). This stenosis reduces the pressure at the afferent arteriole in the kidney. Reduced arteriolar pressure and reduced renal perfusion stimulate Renin release by the kidney.  This increases circulating angiotensin II (AII) and aldosterone. These hormones increase blood volume by enhancing renal reabsorption of sodium and water.  Increased AII causes systemic vasoconstriction and enhances sympathetic activity.  Chronic elevation of AII promotes cardiac and vascular hypertrophy.  The net effect of these renal mechanisms is an increase in blood volume that augments cardiac output by the Frank-Starling mechanism.  Therefore, hypertension caused by renal artery stenosis results from both an increase in systemic vascular resistance and an increase in cardiac output. 2) Chronic renal disease  Diabetic nephropathy or Glomerulonephritis can damage nephrons in the kidney.  When this occurs, the kidney cannot excrete normal amounts of sodium which leads to sodium and water retention, increased blood volume, and increased cardiac output by the Frank-Starling mechanism. Renal disease may also result in increased release of renin leading to a renin-dependent form of hypertension.  The elevation in arterial pressure secondary to renal disease can be viewed as an attempt by the kidney to increase renal perfusion and restore glomerular filtration. 3) Secondary Hypertension (Endocrine)  Pheochromocytoma is a rare (2 to 8 cases per 1 million persons per year)  adrenaline-producing tumor that arises from the Adrenal medulla. High levels of Catecholamines (Norepinephrine). <0.2% of cases of hypertension; all ages ,mainly 30-50 years.  Headaches, Palpitations, Diaphoresis, Severe hypertension  Cushing's syndrome is a collection of symptoms that develop due to very high levels of cortisol hormone.  Conn syndrome (Primary aldosteronism): HTN, Low K, caused by aldosterone- producing adenoma (80% of cases) usually unilateral and solitary. 205
  • 10. 4) Vascular Hypertension: Coarctation of the aorta  It is a congenital condition whereby the aorta narrows in the area where the ductus arteriosus (ligamentum arteriosum after regression) inserts.  The word “coarctation” means narrowing. 206
  • 11. Patent ductus arteriosus  In the developing fetus, the mother provides oxygen and the baby's lungs are filled with fluid.  Blood flow bypasses the lungs through a blood vessel that connects the pulmonary artery (1) with the aorta (2). This blood vessel is called the ductus arteriosus (3).  When the lungs inflate at birth, blood flows through the pulmonary vessels and the ductus arteriosus occludes.  When it remains open after birth it is called a patent ductus arteriosus. In most babies it remains open for a short period of time after birth but 90% will be closed by 8 weeks of age. Most of the rest will close during the first year of life.  In about 1 of every 5500 births this duct fails to close properly and remains patent.  The presence of this duct allows for the backflow of aortic blood into the pulmonary artery. The turbulent blood flow can be detected on auscultation as a murmur.  If not corrected, the continued pulmonary congestion places an excess workload on the heart that can result in heart failure years later.  Surgical correction of patent ductus arteriosus is relatively simple and essentially involves ligation of the ductus arteriosus. 207
  • 12. Physiological mechanisms involved in development of essential hypertension 1) Cardiac output } discussed before 2) Peripheral resistance } discussed before 3) Renin-angiotensin-aldosterone system 4) Autonomic nervous system 5) Other factors:(will be discussed by Endothelial dysfunction) A. Bradykinin B. Endothelin C. EDRF (endothelial derived relaxing factor) or D. Nitric Oxide E. ANP (atrial natriuretic peptide) F. Ouabain 208
  • 13. 3) Renin-Angiotensin-Aldosterone system (RAAS) Summary Renin-angiotensin system (Detailed Figure) 209
  • 14.  The renin-angiotensin system (RAS) or the renin-angiotensin-aldosterone system (RAAS) is a hormone system that regulates blood pressure and water (fluid) balance.  When blood volume is low, the kidneys secrete an enzyme called renin.  Renin stimulates the production of angiotensin.  Angiotensin causes blood vessels to constrict resulting in increased blood pressure.  Angiotensin also stimulates the secretion of the hormone aldosterone from the adrenal cortex.  Aldosterone causes the tubules of the kidneys to increase the reabsorption of sodium and water.  This increases the volume of fluid in the body, which also increases blood pressure.  If the renin-angiotensin-aldosterone system is too active, blood pressure will be too high.  The system can be activated when there is a loss of blood volume or a drop in blood pressure (such as in hemorrhage).  If the perfusion of the juxtaglomerular apparatus in the kidney's macula densa decreases, then the juxtaglomerular cells release the enzyme renin.  Inhibitors of angiotensin-converting enzyme (ACE inhibitors) are often used to reduce the formation of the more potent angiotensin II. Captopril is an example of an ACE inhibitor.  Alternatively, angiotensin receptor blockers (ARBs) can be used to prevent angiotensin II from acting on angiotensin receptors.  Direct renin inhibitors are aliskiren 4) Autonomic nervous system  Sympathetic nervous system (which is a part of autonomic nervous system) stimulation can cause both arteriolar constriction and arteriolar dilatation.  Thus it has an important role in maintaining a normal blood pressure.  It is also important in the mediation of short term changes in blood pressure in response to stress and physical exercise.  Autonomic nervous system: A part of the nervous system that regulates key involuntary functions of the body, including the activity of the heart muscle; the smooth muscles, including the muscles of the intestinal tract; and the glands (breathing, the heartbeat, and digestive processes) 210
  • 15. 5) Endothelium  The endothelium is the inner lining of the arterial wall that comes in direct contact with the blood.  It is composed of a single layer of simple squamous lining cells and polygonal in shape.  A healthy endothelial protects against atherosclerosis.  Nitrite oxide causes the blood vessels to dilate in order to increase blood flow. Abnormal endothelial function causes a reduction in the secretion of nitric oxide. Lack of nitrite oxide causes the blood vessels to constrict instead. Endothelial Function  The healthy endothelium is optimally placed and is able to respond to physical and chemical signals by production of a wide range of factors that regulate vascular tone, cellular adhesion, thromboresistance, smooth muscle cell proliferation, and vessel wall inflammation.  A healthy endothelium maintains a balance between all these different forces. It is normal to have a certain level of constriction, of inflammation, but it should be in balance with all the other functions.  Endothelial dysfunction defined as an imbalance between vasodilating and vasoconstricting substances produced by (or acting on) the endothelium. It may be the result of an injury from high blood glucose, high blood pressure, high cholesterol, smoking, or those cytokines and substances released from visceral fat. 211
  • 16. 212
  • 17. Endothelial Vasoactive Substances Vascular endothelial cells play a key role in cardiovascular regulation by producing a number of potent local Vasoactive Substances:  Bradykinin is a potent endothelium-dependent vasodilator, leading to a drop in blood pressure. o It also causes contraction of non-vascular smooth muscle in the bronchus and gut, increases vascular permeability. o Bradykinin also causes natriuresis (excretion of sodium in the urine), contributing to the drop in blood pressure. o Bradykinin is also thought to be the cause of the dry cough in some patients on angiotensin-converting enzyme (ACE) inhibitor drugs. o It is thought that bradykinin is converted to inactive metabolites by ACE, therefore inhibition of this enzyme leads to increased levels of bradykinin, which causes a dry cough via bronchoconstriction.  Endothelin is a powerful, vascular, endothelial vasoconstrictor, which may produce a salt sensitive rise in blood pressure. It also activates local rennin angiotensin systems.  Endothelial derived relaxant factor (EDRF) or Nitric Oxide (NO), is produced by arterial and venous endothelium and diffuses through the vessel wall into the smooth muscle causing vasodilatation  Atrial natriuretic peptide is a hormone secreted from the atria of the heart in response to increased blood volume. o Its effect is to increase sodium and water excretion from the kidney as a sort of natural diuretic. o A defect in this system may cause fluid retention and hypertension. o Sodium transport across vascular smooth muscle cell walls is also thought to influence blood pressure via its interrelation with calcium transport.  Ouabain may be a naturally occurring steroid›like substance which is thought to interfere with cell sodium and calcium transport, giving rise to vasoconstriction. 213
  • 18. Endothelium-Derived Contracting Factors (EDCFs) include endothelin-1, angiotensin II, thromboxane A2 (TxA2), prostaglandin H2, and reactive oxygen species (ROS). HTN Risk Factors  Although the cause or causes of essential hypertension are largely unknown, several constitutional factors have been implicated as contributing to its development.  These risk factors include family history of hypertension, race, diabetes mellitus, and age-related increases in blood pressure.  Hypertension not only is more prevalent in African Americans than whites, it is more severe, tends to occur earlier, and often is not treated early enough or aggressively enough. Blacks also tend to develop greater cardiovascular and renal damage at any level of pressure.  Diabetes mellitus and hypertension are closely interrelated disorders that share similar genetic and life-style factors.  Lifestyle Factors: These lifestyle factors include high sodium intake, excessive calorie intake and obesity, physical inactivity, and excessive alcohol consumption.  Oral contraceptive drugs also may increase blood pressure in predisposed women. 214
  • 19.  Although stress can raise blood pressure acutely, there is less evidence linking it to chronic elevations in blood pressure.  Dietary fats and cholesterol are independent risk factors for cardiovascular disease, but there is no evidence that they raise blood pressure.  Smoking, although not identified as a primary risk factor in hypertension, is an independent risk factor in coronary heart disease and should be avoided. Manifestations of Hypertension  Essential hypertension is typically an asymptomatic disorder.  When symptoms do occur they are usually related to the long- term effects of hypertension on other organ systems of the body including the kidneys, heart, eyes, and blood vessels.  Diastolic blood pressure is the best predictor of cardiovascular disease in young people.  Systolic blood pressure is the dominant predictor of risk of cardiovascular disease in older people 215
  • 20. Hypotension  Hypotension is an abnormally low blood pressure.  One common form of hypotension is orthostatic hypotension (also called postural hypotension) that occurs upon standing.  Orthostatic hypotension is a systolic blood pressure decrease of at least 20 mm Hg or a diastolic blood pressure decrease of at least 10 mm Hg within three minutes of standing.  In healthy persons, muscle contraction increases venous return of blood to the heart through one-way valves that prevent blood from pooling in dependent parts of the body.  The autonomic nervous system responds to changes in position by constricting veins and arteries and increasing heart rate and cardiac contractility.  When these mechanisms are faulty or if the patient is hypovolemic, orthostatic hypotension may occur.  More common in: Elderly pts with systolic HTN , DM, Pts on diuretics, vasodilators, or some psychotropic drugs  In persons with orthostatic hypotension, gravitational opposition to venous return causes a decrease in blood pressure and threatens cerebral ischemia. Causes of Orthostatic Hypotension 1) Aging — Associated with reduced baroreceptor responses, decreased cardiac output and reduced vascular responsiveness 2) Decreased blood or fluid volume — Caused by dehydration, diarrhea, diuretic use 3) Autonomic nervous defects — An inability to initiate vasoconstriction and increased heart rate reflexes 4) Prolonged bed rest — Associated with reduced plasma volume, decreased vascular tone 5) Drug-induced — Examples: antihypertensive drugs, calcium channel blockers, vasodilators 6) Idiopathic — Cause is not known Orthostatic hypotension  Manifestations  Dizziness (syncopy)  Decreased cardiac output  Reduced brain blood flow 216
  • 21.  Pooling of blood in the extremities  Falls and injuries, particularly in elderly individuals  Treatment  Maintain fluid volume.  If patient is lying down, have the patient first sit for several minutes to allow blood pressure to equilibrate, then have patient stand slowly.  Provide elastic support garments and stockings that may help prevent pooling of blood in the lower extremities. -------------------------------- 217